Efficacy and safety of generic escitalopram (Lexacure(®)) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram-comparative, non-inferiority study

OBJECTIVES: The primary aim of this non-inferiority study was to investigate the clinical effectiveness and safety of generic escitalopram (Lexacure(®)) versus branded escitalopram (Lexapro(®)) for patients with major depressive disorder (MDD). METHODS: The present study included 158 patients, who w...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuropsychiatr Dis Treat
Main Authors: Jeong, Jong-Hyun, Bahk, Won-Myong, Woo, Young Sup, Lee, Kyung-Uk, Kim, Do Hoon, Kim, Moon-Doo, Kim, Won, Yang, Jong-Chul, Lee, Kwang Heun
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2015
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4605251/
https://ncbi.nlm.nih.gov/pubmed/26504387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S90796
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares